Ogivri

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OGIVRI® contains the active ingredient trastuzumab (rch) Consumer Medicine Information What is

Read more
Sifrol ER

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIFROL ER CMI0120-08 extended-release tablets pramipexole dihydrochloride monohydrate Consumer Medicine Information What

Read more